Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Compact testing strips
0601060D0BVAAA0
|
Compact (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Conj oestrogens 1.25mg tab and Norgestrel 150microg tab
0604011Q0AAADAD
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Conj oestrogens 625microg tab and Norgestrel 150microg tab
0604011Q0AAACAC
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Conjugated oestrogens 2.5mg tablets
0604011P0AAADAD
|
Oestro Conj (Systemic) | Oestrogens conjugated | Endocrine System | No data available |
|
Conjugated oestrogens 450microg / Bazedoxifene 20mg MR tab
0604011ADAAAAAA
|
Conjugated oestrogens / bazedoxifene | Oestrogens conjugated with bazedoxifene | Endocrine System | No data available |
|
Conjugated oestrogens 625microg/Medroxyprogesterone 5mg tab
0604011Q0AAAEAE
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Corifollitropin alfa 100micrograms/0.5ml inj pfs
0605010ADAAAAAA
|
Corifollitropin alfa | Corifollitropin alfa | Endocrine System | No data available |
|
Corifollitropin alfa 150micrograms/0.5ml inj pfs
0605010ADAAABAB
|
Corifollitropin alfa | Corifollitropin alfa | Endocrine System | No data available |
|
Corticotropin 400units/5ml gel for injection vials
0605010J0AAAFAF
|
Cortico | Corticotropin | Endocrine System | No data available |
|
Cortisone 2.5mg/5ml oral liquid
0603020F0AAAJAJ
|
Cortisone acetate | Cortisone acetate | Endocrine System | No data available |
|
Cortisone 5mg capsules
0603020F0AAAKAK
|
Cortisone acetate | Cortisone acetate | Endocrine System | No data available |
|
Cortisone 5mg/5ml oral suspension
0603020F0AAAMAM
|
Cortisone acetate | Cortisone acetate | Endocrine System | No data available |
|
CozyLab S7 testing strips
0601060D0CMAAA0
|
CozyLab S7 (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Crinone 4% progesterone vaginal gel
0604012S0BGAAAV
|
Crinone | Progesterone | Endocrine System | No data available |
|
Cyclo-Progynova 1mg tablets
0604011L0BCAAAB
|
Cyclo-Progynova | Estradiol with progestogen | Endocrine System | No data available |
|
Cyclomen 50mg capsules
0607020C0BCAAAE
|
Cyclomen | Danazol | Endocrine System | No data available |
|
Cyproterone 10mg tablets
0604020D0AAABAB
|
Cyprote acetate (Male Hormone) | Cyproterone acetate | Endocrine System | No data available |
|
Danazol 35mg capsules
0607020C0AAADAD
|
Danazol | Danazol | Endocrine System | No data available |
|
Danazol 50mg capsules
0607020C0AAAEAE
|
Danazol | Danazol | Endocrine System | No data available |
|
Danol 200mg capsules
0607020C0BBAAAB
|
Danol | Danazol | Endocrine System | No data available |
|
Daonil 5mg tablets
0601021H0BBAAAB
|
Daonil | Glibenclamide | Endocrine System | No data available |
|
DDAVP 100microg/ml intranasal soln (Imported(Netherlands))
0605020E0BBAJAB
|
DDAVP | Desmopressin acetate | Endocrine System | No data available |
|
DDAVP 100micrograms/ml intranasal soln (Imported(Canada))
0605020E0BBAIAB
|
DDAVP | Desmopressin acetate | Endocrine System | No data available |
|
DDAVP 100micrograms/ml intranasal soln (Imported(Germany))
0605020E0BBAKAB
|
DDAVP | Desmopressin acetate | Endocrine System | No data available |
|
Decadron 500microgram tablets
0603020G0BBAAAB
|
Decadron | Dexamethasone | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.